180 related articles for article (PubMed ID: 37081431)
1. Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study.
Liu X; Sun K; Yang H; Xia L; Lu K; Meng X; Li Y
BMC Cancer; 2023 Apr; 23(1):361. PubMed ID: 37081431
[TBL] [Abstract][Full Text] [Related]
2. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
Jia M; Pan L; Yang H; Gao J; Guo F
Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
[No Abstract] [Full Text] [Related]
4. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
5. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
[TBL] [Abstract][Full Text] [Related]
6. Time trend of breast cancer-related lymphedema according to body mass index.
Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema.
Kwan JYY; Famiyeh P; Su J; Xu W; Kwan BYM; Jones JM; Chang E; Yip KW; Liu FF
JAMA Netw Open; 2020 Nov; 3(11):e2024373. PubMed ID: 33175175
[TBL] [Abstract][Full Text] [Related]
8. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
9. Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years.
Tomić S; Malenković G; Mujičić E; Šljivo A; Tomić SD
BMC Womens Health; 2024 Apr; 24(1):226. PubMed ID: 38582869
[TBL] [Abstract][Full Text] [Related]
10. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies.
Shen A; Lu Q; Fu X; Wei X; Zhang L; Bian J; Qiang W; Pang D
Support Care Cancer; 2022 Dec; 31(1):18. PubMed ID: 36513801
[TBL] [Abstract][Full Text] [Related]
12. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
13. A 4-Year Institutional Experience of Immediate Lymphatic Reconstruction.
Granoff MD; Fleishman A; Shillue K; Johnson AR; Ross J; Lee BT; Teller P; James TA; Singhal D
Plast Reconstr Surg; 2023 Nov; 152(5):773e-778e. PubMed ID: 36877759
[TBL] [Abstract][Full Text] [Related]
14. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Impact of Immediate Lymphatic Reconstruction for the Surgical Prevention of Lymphedema.
Johnson AR; Fleishman A; Granoff MD; Shillue K; Houlihan MJ; Sharma R; Kansal KJ; Teller P; James TA; Lee BT; Singhal D
Plast Reconstr Surg; 2021 Mar; 147(3):373e-381e. PubMed ID: 33620920
[TBL] [Abstract][Full Text] [Related]
16. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors.
Liu YF; Liu JE; Zhu Y; Mak YW; Qiu H; Liu LH; Yang SS; Chen SH
Support Care Cancer; 2021 Sep; 29(9):5435-5445. PubMed ID: 33704565
[TBL] [Abstract][Full Text] [Related]
18. Validation of a breast cancer nomogram to predict lymphedema in a Chinese population.
Li X; Huang H; Lin Q; Yu Q; Zhou Y; Long W; Wang N
J Surg Res; 2017 Apr; 210():132-138. PubMed ID: 28457319
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.
Gross JP; Whelan TJ; Parulekar WR; Chen BE; Rademaker AW; Helenowski IB; Donnelly ED; Strauss JB
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):165-173. PubMed ID: 31085285
[TBL] [Abstract][Full Text] [Related]
20. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
